Investigating how microRNAs affect the development of Type 1 diabetes
β cell miRNAs Function as Molecular Hubs of Type 1 Diabetes Pathogenesis
This study is looking at tiny molecules called microRNAs to see how they might affect the damage to insulin-producing cells in people with Type 1 diabetes, with the hope of finding new ways to help manage the condition better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-10831964 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of microRNAs in the pathogenesis of Type 1 diabetes (T1D), a condition where the immune system attacks insulin-producing β cells. The study examines how these small RNA molecules influence cell death and autoimmune responses within the pancreas. By analyzing changes in microRNA expression in human islets and their extracellular vesicles in response to inflammatory signals, the research aims to uncover new insights into the mechanisms driving T1D. This could lead to novel therapeutic strategies that target these pathways to improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Type 1 diabetes, particularly those experiencing rapid disease progression or complications.
Not a fit: Patients with Type 2 diabetes or other forms of diabetes unrelated to autoimmune mechanisms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that prevent or slow the progression of Type 1 diabetes.
How similar studies have performed: Previous research has shown that targeting microRNAs can influence disease processes in other autoimmune conditions, suggesting potential for success in this area as well.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Evans-Molina, Carmella — Indiana University Indianapolis
- Study coordinator: Evans-Molina, Carmella
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.